Skip to search formSkip to main contentSkip to account menu

Acomplia

Known as: Zimulti 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Review
2014
Review
2014
Endocannabinoids are lipid mediators able to bind to and activate cannabinoid receptors, the primary molecular targets… 
Review
2009
Review
2009
Highly Cited
2007
Highly Cited
2007
Rimonabant (AcompliaTM, SR141716A), a cannabinoid CB1 receptor inverse agonist, has recently been approved for the treatment of… 
Review
2007
Review
2007
The advent of the highly selective cannabinoid receptor (CB1) antagonist, rimonabant (SR141716; Acomplia) can revolutionize the… 
Highly Cited
2005
Highly Cited
2005
It is well established that Cannabis sativa can increase appetite, particularly for sweet and palatable foods. In laboratory…